Vascular endothelial growth factor is a marker of prognostic relevance and a predictor for an early recurrence after curative resection of ductal adenocarcinoma of the pancreas (Niedergethmann et al, 2002). This evidence concerns the gene VEGFA and pancreatic ductal adenocarcinoma.